KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)

KMPHARMACEUTICAL Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,517	19,103	27,274	44,340	62,049	81,291
Market Cap Growth	-12.63%	-29.96%	-38.49%	-28.54%	-23.67%	36.48%
Enterprise Value	33,204	32,128	39,519	56,196	64,798	98,622
Last Close Price	664.00	685.00	978.00	1590.00	2225.00	2915.00
PE Ratio	-	-	-	-	-	172.64
PS Ratio	1.32	1.32	1.54	2.84	2.73	3.55
PB Ratio	0.60	0.59	0.77	1.22	1.56	1.99
P/TBV Ratio	0.60	0.59	0.77	1.22	1.56	2.00
P/FCF Ratio	-	-	20.45	-	-	-
P/OCF Ratio	-	-	18.86	-	27.37	89.41
EV/Sales Ratio	2.37	2.22	2.22	3.60	2.85	4.30
EV/EBITDA Ratio	-	-	154.53	-	28.07	53.18
EV/EBIT Ratio	-	-	-	-	74.81	138.45
EV/FCF Ratio	-12.85	-	29.64	-	-	-
Debt / Equity Ratio	0.48	0.43	0.35	0.37	0.24	0.18
Debt / EBITDA Ratio	-	-	48.67	-	4.19	4.04
Debt / FCF Ratio	-	-	9.34	-	-	-
Asset Turnover	0.29	0.29	0.35	0.30	0.44	0.49
Inventory Turnover	4.48	4.52	5.32	4.76	5.80	5.37
Quick Ratio	0.12	0.23	0.28	0.23	0.86	2.80
Current Ratio	0.41	0.51	0.50	0.51	1.32	3.90
Return on Equity (ROE)	-14.29%	-13.43%	-3.68%	-10.30%	-1.52%	1.45%
Return on Assets (ROA)	-4.78%	-4.83%	-1.37%	-4.47%	1.05%	0.95%
Return on Capital (ROIC)	-5.00%	-5.08%	-1.43%	-4.69%	1.11%	1.00%
Return on Capital Employed (ROCE)	-	-	-	-	1.90%	1.50%
Earnings Yield	-24.91%	-23.94%	-4.84%	-8.85%	-0.98%	0.58%
FCF Yield	-13.96%	-12.57%	4.89%	-0.34%	-0.16%	-3.48%
Buyback Yield / Dilution	0.30%	0.71%	-0.90%	-0.20%	-29.80%	-2.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.